HLA-E and cancer: This pathway comprises several genes involved in the crosstalk between beta cells and the immune system, such as PDL1 (CD274), an immune checkpoint protein expressed in the islets of T1D individuals24, and a second co-inhibitory molecule, HLA-E, recently identified as potential target for cancer immunotherapy25 (Fig. 2d–m).